{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T21:52:34Z","timestamp":1785707554132,"version":"3.56.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.opresp.2025.100488","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:15:08Z","timestamp":1756768508000},"page":"100488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nosocomial and Ventilator-associated Pneumonia"],"prefix":"10.1016","volume":"7","author":[{"given":"Carlos","family":"Cabanillas D\u00edez-Madro\u00f1ero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Raboso Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Urrutia-Royo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imanol","family":"Gonz\u00e1lez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Erro Iribarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pou \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gonz\u00e1lez Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.opresp.2025.100488_bib0325","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for HAP\/VAP of ERS, ESICM, ESCMID & ALAT","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2025.100488_bib0330","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0335","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/ice.2022.88","article-title":"Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update","volume":"43","author":"Klompas","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.opresp.2025.100488_bib0340","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":"Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0345","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00134-010-1824-6","article-title":"Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models","volume":"36","author":"Nguile-Makao","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0350","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/CCM.0000000000005298","article-title":"Descriptive epidemiology and outcomes of non-ventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2012\u20132019","volume":"50","author":"Zilberberg","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.idc.2023.12.004","article-title":"Management of ventilator-associated pneumonia: guidelines","volume":"38","author":"Metersky","year":"2024","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.opresp.2025.100488_bib0360","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0229-2024","article-title":"Biomarkers in lower respiratory tract samples in the diagnosis of ventilator-associated pneumonia: a systematic review","volume":"34","author":"Gromelsky Ljungcrantz","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.opresp.2025.100488_bib0365","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/518460","article-title":"Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia","volume":"28","author":"Weber","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.opresp.2025.100488_bib0370","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.32.1700843","article-title":"Healthcare-associated pneumonia in acute-care hospitals in European Union\/European Economic Area countries: analysis of data from a point prevalence survey, 2011\u20132012","volume":"23","author":"Walter","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.opresp.2025.100488_bib0375","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/ice.2021.464","article-title":"Microbiology, empiric therapy and its impact on outcomes of non-ventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the U.S., 2014\u20132019","volume":"43","author":"Zilberberg","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.opresp.2025.100488_bib0380","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by IDSA and ATS","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0385","article-title":"Independent risk factors and outcomes for ventilator-associated pneumonia due to multidrug-resistant organisms after cardiac valvular surgery","volume":"12","author":"Chen","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.opresp.2025.100488_bib0390","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12872-022-02890-5","article-title":"Risk factors for ventilator-associated pneumonia due to multidrug-resistant organisms after cardiac surgery in adults","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.opresp.2025.100488_bib0395","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s00134-005-2697-y","article-title":"Early- and late-onset VAP are caused mainly by potentially multiresistant bacteria","volume":"31","author":"Giantsou","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0400","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1183\/09031936.02.00012902","article-title":"Nosocomial tracheobronchitis in mechanically ventilated patients","volume":"20","author":"Nseir","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.opresp.2025.100488_bib0405","first-page":"409","article-title":"Resistance patterns and outcomes in ICU-acquired pneumonia","volume":"42","author":"Martin-Loeches","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0410","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.3390\/jcm12206526","article-title":"Ten issues to update in nosocomial or hospital-acquired pneumonia: an expert review","volume":"12","author":"Candel","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0415","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcrc.2007.08.007","article-title":"Impact of inappropriate antibiotic therapy on mortality in patients with VAP and bloodstream infection: a meta-analysis","volume":"23","author":"Kuti","year":"2008","journal-title":"J Crit Care"},{"key":"10.1016\/j.opresp.2025.100488_bib0420","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/microorganisms12071422","article-title":"Risk factors, pathogens, and outcomes of ventilator-associated pneumonia in non-cardiac surgical patients","volume":"12","author":"Chang","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.opresp.2025.100488_bib0425","first-page":"327","article-title":"Antimicrobial stewardship: another focus for patient safety?","volume":"34","author":"Tamma","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0430","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0435","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.08-1357","article-title":"Healthcare-associated pneumonia among hospitalized patients in a Japanese community hospital","volume":"135","author":"Shindo","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.opresp.2025.100488_bib0440","first-page":"525","article-title":"Risk factors for VAP","volume":"23","author":"Kollef","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.opresp.2025.100488_bib0445","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00003246-199905000-00020","article-title":"Nosocomial infections in ICU in the United States","volume":"27","author":"Richards","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0450","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3201\/eid0702.010226","article-title":"Biofilms and device-associated infections","volume":"7","author":"Donlan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0455","series-title":"Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level","year":"2016"},{"key":"10.1016\/j.opresp.2025.100488_bib0460","series-title":"Management of multidrug-resistant organisms in healthcare settings","year":"2019"},{"key":"10.1016\/j.opresp.2025.100488_bib0465","first-page":"605","article-title":"Risk factors for VAP and strategies to prevent it","volume":"4","author":"Bonten","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0470","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","article-title":"Rationalizing antimicrobial therapy in the ICU: a narrative review","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0475","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arbres.2020.01.015","article-title":"Normativa SEPAR: neumon\u00eda intrahospitalaria Normativa SEPAR","volume":"56","author":"Torres","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2025.100488_bib0480","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16517.1","article-title":"Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria","volume":"8","author":"Watkins","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.opresp.2025.100488_bib0485","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","article-title":"Ceftazidime\u2013avibactam versus meropenem in nosocomial pneumonia, including VAP (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial","volume":"18","author":"Torres","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0490","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1473-3099(19)30403-7","article-title":"Ceftolozane\u2013tazobactam versus meropenem for nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3 non-inferiority trial","volume":"19","author":"Kollef","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2023.12.006","article-title":"Infectious pulmonary diseases","volume":"38","author":"Rafeq","year":"2024","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.opresp.2025.100488_bib0500","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/healthcare11091345","article-title":"Trends in molecular diagnosis of nosocomial pneumonia: classic PCR vs. point-of-care PCR","volume":"11","author":"B\u0103lan","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.opresp.2025.100488_bib0505","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01616-22","article-title":"Impact of molecular syndromic diagnosis of severe pneumonia in management of critically ill patients","volume":"10","author":"Stafylaki","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.opresp.2025.100488_bib0510","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/antibiotics13010095","article-title":"Impact of multiplex PCR in the therapeutic management of severe bacterial pneumonia","volume":"13","author":"Dessajan","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.opresp.2025.100488_bib0515","first-page":"88","article-title":"Randomised controlled trial of rapid molecular diagnostics and antibiotic stewardship to optimise clinical management of HAP and VAP (INHALE WP3)","volume":"51","author":"Enne","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0520","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jmii.2024.02.010","article-title":"Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship in ICU patients with HAP\/VAP","volume":"57","author":"Chen","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.opresp.2025.100488_bib0525","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCP.0000000000000668","article-title":"Advances in molecular diagnostic tests for pneumonia","volume":"26","author":"Cill\u00f3niz","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0530","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0041-1739359","article-title":"Classical and molecular techniques to diagnose HAP\/VAP","volume":"43","author":"Renaud","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0535","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","article-title":"ICU-acquired infections in immunocompromised patients","volume":"50","author":"Kreitmann","year":"2024","journal-title":"Intensive Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.opresp.2025.100488_bib0540","first-page":"S46","article-title":"Molecular detection of Candida spp. and Aspergillus fumigatus in bronchoalveolar lavage fluid of patients with VAP","volume":"19","author":"Khorvash","year":"2014","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.opresp.2025.100488_bib0545","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/jof8111167","article-title":"The pathogenesis and diagnosis of Pneumocystis jiroveci pneumonia","volume":"8","author":"Fishman","year":"2022","journal-title":"J Fungi"},{"key":"10.1016\/j.opresp.2025.100488_bib0550","first-page":"84","article-title":"Viral ventilator-associated pneumonia\/hospital-acquired pneumonia","volume":"43","author":"Luyt","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0555","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-0041-1740605","article-title":"New antibiotics for hospital-acquired and ventilator-associated pneumonia","volume":"43","author":"Bassetti","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100488_bib0560","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/antibiotics13070629","article-title":"Novel antibiotics for Gram-negative nosocomial pneumonia","volume":"13","author":"Almyroudi","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.opresp.2025.100488_bib0565","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cid\/ciz530","article-title":"RESTORE-IMI 1: a multicenter, randomized, double-blind trial comparing imipenem\/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections","volume":"70","author":"Motsch","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0570","doi-asserted-by":"crossref","first-page":"e4539","DOI":"10.1093\/cid\/ciaa803","article-title":"A randomized, double-blind, multicenter trial comparing imipenem\/cilastatin\/relebactam versus piperacillin\/tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia (RESTORE-IMI 2)","volume":"73","author":"Titov","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0575","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","article-title":"Effect and safety of meropenem\u2013vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial","volume":"7","author":"Wunderink","year":"2018","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.opresp.2025.100488_bib0580","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab371","article-title":"Real-world, multicenter experience with meropenem\u2013vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa","volume":"8","author":"Alosaimy","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0585","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/fmb-2023-0197","article-title":"Perspectives on the use of ceftolozane\/tazobactam: review of clinical trial data and real-world evidence","volume":"19","author":"Martin-Loeches","year":"2024","journal-title":"Future Microbiol"},{"key":"10.1016\/j.opresp.2025.100488_bib0590","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13613-022-01084-8","article-title":"Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane\/tazobactam versus meropenem: subset analysis of ASPECT-NP trial","volume":"13","author":"Martin-Loeches","year":"2023","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.opresp.2025.100488_bib0595","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3 non-inferiority trial","volume":"21","author":"Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0600","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/ciu219","article-title":"A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for treatment of hospital-acquired pneumonia","volume":"59","author":"Awad","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0605","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.arbres.2011.05.013","article-title":"Normativa SEPAR: neumon\u00eda nosocomial","volume":"47","author":"Blanquer","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.opresp.2025.100488_bib0610","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.21037\/jtd.2016.12.89","article-title":"Duration of antibiotic therapy in the ICU","volume":"8","author":"Zilahi","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.opresp.2025.100488_bib0615","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults","volume":"8","author":"Pugh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.opresp.2025.100488_bib0620","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2025.100488_bib0625","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.idc.2023.12.005","article-title":"The role of biomarkers in the diagnosis and management of pneumonia","volume":"38","author":"Sungurlu","year":"2024","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.opresp.2025.100488_bib0630","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.opresp.2025.100488_bib0635","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13613-017-0338-6","article-title":"Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis","volume":"7","author":"Huang","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"10","key":"10.1016\/j.opresp.2025.100488_bib0640","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S265966362500092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S265966362500092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:52:47Z","timestamp":1780933967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S265966362500092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S265966362500092X"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2025.100488","relation":{},"ISSN":["2659-6636"],"issn-type":[{"value":"2659-6636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nosocomial and Ventilator-associated Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2025.100488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100488"}}